Família Lactate Dehydrogenase acc. to IFCC ver.2

Lactate dehydrogenase (LDH) - tumor marker · class III · Until 21/09/2036

Registration no.
10287411812
Process no.
25351127586202647
Status
Until 21/09/2036
Device type
Lactate dehydrogenase (LDH) - tumor marker (LACTATO DESIDROGENASE (LDH) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER)
Risk class
III
Registration holder
ROCHE DIAGNÓSTICA BRASIL LTDA CNPJ 30.280.358/0001-86 · 1,784 registrations
Manufacturer
ROCHE DIAGNOSTICS GMBH · Germany
Published
21/09/2026
Valid until
21/09/2036
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other lactate dehydrogenase (ldh) - tumor marker registrations (4 in total, see all)

ProductClass HolderPublishedStatus
LDH (IFCC)
80254180494
III PHADIA DIAGNOSTICOS LTDA 05/10/2026 Until 05/10/2036
Lactate Dehydrogenase2 (LDH2)
80146502431
III ABBOTT LABORATORIOS DO BRASIL LTDA 27/07/2026 Until 27/07/2036
Alinity c Lactate Dehydrogenase2 (LDH2)
80146502432
III ABBOTT LABORATORIOS DO BRASIL LTDA 27/07/2026 Until 27/07/2036